Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300118
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $19,326
Award facts
- Contract value 33% obligated
-
- $19,326.41 Current, with exercised options
- $57,979.23 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46250, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN26300118?
HHSN26300118 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on February 28, 2013.
How much is contract HHSN26300118 worth?
The government has obligated $19,326 on HHSN26300118. Its potential value, with all options, is $57,979.
Is contract HHSN26300118 an order under another contract?
Yes. HHSN26300118 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26300118 competed?
The extent of competition for HHSN26300118 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award